Liu Shuai, Dai Anran, Meng Lulu, Zhou Yong, Li Mingde, Huo Xingxing
Clinical Research and Experimental Center, the First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China.
Clinical Research and Experimental Center, the First Affiliated Hospital, Anhui University of Chinese Medicine, Hefei 230031, China. *Corresponding author, E-mail:
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2022 Sep;38(9):853-857.
Regulatory B cells (Bregs) are a group of B cells with negative immune regulation, which produce negative regulatory cytokines, such as interleukin-10 (IL-10), transform growth factor β (TGF- β), or participate in immune regulation and inhibit inflammatory response by intercellular activities. B10 cells are a kind of Bregs that generates IL-10. In recent years, a large number of studies have reported that B10 cells are involved in the development of a variety of autoimmune diseases. Here, we make a systematic review of the origin and immune mechanism of B10 cells, their roles in autoimmune diseases (rheumatoid arthritis, inflammatory bowel disease and Sjogren's syndrome, etc.) and regulations, coupled with its applications in the treatment of autoimmune diseases.We also discussed the B10 cells as a potential method feasible for treating autoimmune diseases.
调节性B细胞(Bregs)是一类具有负向免疫调节作用的B细胞,它们产生白细胞介素-10(IL-10)、转化生长因子β(TGF-β)等负向调节细胞因子,或通过细胞间活动参与免疫调节并抑制炎症反应。B10细胞是一种能产生IL-10的Bregs。近年来,大量研究报道B10细胞参与多种自身免疫性疾病的发生发展。在此,我们对B10细胞的起源和免疫机制、它们在自身免疫性疾病(类风湿关节炎、炎症性肠病和干燥综合征等)中的作用及调节,以及其在自身免疫性疾病治疗中的应用进行系统综述。我们还讨论了将B10细胞作为治疗自身免疫性疾病的一种可行潜在方法。